| Financial Summary | | Galen
Holdings
PLC
is
an
integrated
specialty
pharmaceutical
company
focused
in
the
women's
healthcare
therapeutic
area.
For
the
nine
months
ended
6/30/01,
revenues
totaled
L132.9
million,
up
from
L63.8
million.
Net
income
decreased
35%
to
L8.2
million.
Revenues
reflect
a
benefit
from
the
Warner
Chilcott
division
which
was
acquired
in
9/00.
Net
income
was
offset
by
higher
acquisition-related
costs
and
an
increase
in
average
borrowings. | More
from
Market Guide: Significant
Developments |
| Officers | | Dr. John
A. King,
Chmn. Roger
M. Boissonneault,
CEO R. Geoffrey
Elliott,
CFO. | More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|